logoTry Persana

Altay Therapeutics - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Altay Therapeutics including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Altay Therapeutics company logo

We develop small molecule drugs targeting disease-causing transcription factors to treat chronic illnesses and cancers

Altay Therapeutics develops novel small molecule drugs targeting disease-causing transcription factors to treat chronic illnesses and cancers.

HeadquartersSan Francisco, United States
Team size1-10
Founded2019

What is Altay Therapeutics? - Company Overview & Details

Altay Therapeutics is Altay Therapeutics develops novel small molecule drugs targeting disease-causing transcription factors to treat chronic illnesses and cancers. Founded in 2019, the company is headquartered in San Francisco, United States.

Who Founded Altay Therapeutics?

Altay Therapeutics was founded by Ali Ozes.

Who are the Key Executives at Altay Therapeutics? - Leadership Team

Altay Therapeutics is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Altay Therapeutics

Ali OzesCEO

Chief Technology Officer (CTO) of Altay Therapeutics

CTO

About Ali Ozes - CEO of Altay Therapeutics

Ali Ozes serves as the Chief Executive Officer of Altay Therapeutics, leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

Altay Therapeutics Company Details & Key Information

Where is Altay Therapeutics located?

Altay Therapeutics is headquartered in San Francisco, United States.

How many employees does Altay Therapeutics have?

Altay Therapeutics has 1-10 employees.

When was Altay Therapeutics founded?

Altay Therapeutics was founded in 2019.

Altay Therapeutics Official Website

How much funding has Altay Therapeutics raised?

Altay Therapeutics has raised $3 Million across 1 funding rounds. The most recent funding was completed on 2022-09-21.

Funding Overview

SOLVE FSHD invested $3 million in Altay Therapeutics to support its mission of developing therapies targeting DUX4.

$3 Million
Total Funding Raised
1
Funding Rounds
2022-09-21
Latest Round

Altay Therapeutics Funding History

Venture Capital
2022-09-21
$3 Million

Who are the key investors in Altay Therapeutics?

Altay Therapeutics is backed by 1 key investors including SOLVE FSHD. These investors focus on Biotechnology, Funding for medical research sectors.

Altay Therapeutics Investor Overview

1
Key Investors
2
Focus Areas
1
Notable Investments

Complete List of Altay Therapeutics Investors

SOLVE FSHD

Venture-philanthropy organization focused on accelerating a cure for FSHD.

Investment Focus
Biotechnology
Funding for medical research
Notable Portfolio Companies
$3 million in Altay Therapeutics

What sectors do Altay Therapeutics investors focus on?

The investors backing Altay Therapeutics primarily focus on Biotechnology, Funding for medical research sectors.

Biotechnology
Funding for medical research

Featured Investor: SOLVE FSHD

SOLVE FSHD

Venture-philanthropy organization focused on accelerating a cure for FSHD.

Notable Investments: $3 million in Altay Therapeutics

What are Altay Therapeutics's future plans?

Altay Therapeutics Continue advancing drug development and prepare for clinical trials.

Altay Therapeutics Strategic Outlook

Strategic Focus
Defined
2
Key Challenges
2
Growth Opportunities

What challenges does Altay Therapeutics face?

Altay Therapeutics has identified 2 key challenges that need to be addressed for continued growth and success.

Key Challenges for Altay Therapeutics

1

Regulatory approval processes

2

Funding for further research

What opportunities does Altay Therapeutics have?

Altay Therapeutics has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for Altay Therapeutics

1

Expanding clinical trials

2

Developing partnerships in biotechnology

Altay Therapeutics Strategic Position Summary

Key Focus Areas

Altay Therapeutics is addressing 2 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about Altay Therapeutics?

Altay Therapeutics has 1 recent news updates covering key business developments and market activities.

Altay Therapeutics News Overview

1
Recent Articles
Active
Media Coverage
2022-09-21
Latest Update

What is Altay Therapeutics in the news for?

Altay Therapeutics is currently featured in news for Altay Therapeutics receives financing of $3M. and other significant business developments.

Recent News Articles About Altay Therapeutics

Article 1
2022-09-21

Altay Therapeutics receives financing of $3M.

SOLVE FSHD invested $3 million in Altay Therapeutics to support its innovative drug development efforts.

solvefshd.com
Read News

Altay Therapeutics FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Altay Therapeutics including information about founders, CEO, funding history, investors, headquarters location, and company details. 18 frequently asked questions covering key information about the company.

Altay Therapeutics Questions & Answers - Company Information

Q1

What is Altay Therapeutics?

Altay Therapeutics develops novel small molecule drugs targeting disease-causing transcription factors to treat chronic illnesses and cancers.

Q2

Who founded Altay Therapeutics?

Altay Therapeutics was founded by Ali Ozes.

Q3

Who is the CEO of Altay Therapeutics?

The CEO of Altay Therapeutics is Ali Ozes. You can find more information about them on their LinkedIn profile.

Q4

How much funding has Altay Therapeutics raised?

Altay Therapeutics has raised a total of $$3 Million across 1 funding rounds. The most recent funding was completed on 2022-09-21.

Q5

Who are the investors in Altay Therapeutics?

Altay Therapeutics's key investors include SOLVE FSHD.

Q6

Where is Altay Therapeutics headquartered?

Altay Therapeutics is headquartered in San Francisco, United States.

Q7

When was Altay Therapeutics founded?

Altay Therapeutics was founded in 2019.

Q8

How many employees does Altay Therapeutics have?

Altay Therapeutics has 1-10 employees.

Q9

What is Altay Therapeutics's official website?

You can visit Altay Therapeutics's official website at http://www.altaytherapeutics.com.

Q10

What was Altay Therapeutics's latest funding round?

Altay Therapeutics's latest funding round was a Venture Capital round of $$3 Million completed on 2022-09-21.

Q11

Who is founder?

Ali Ozes

Q12

What does the company do?

Altay Therapeutics develops novel small molecule drugs targeting disease-causing transcription factors to treat chronic illnesses and cancers.

Q13

How much funding?

$3 Million

Q14

Latest funding date?

2022-09-21

Q15

Who are the investors?

SOLVE FSHD

Q16

What are the challenges?

Regulatory approval processes Funding for further research

Q17

What are the opportunities?

Expanding clinical trials Developing partnerships in biotechnology

Q18

Latest news?

SOLVE FSHD invested $3 million in Altay Therapeutics to support its innovative drug development efforts.

More Information About Altay Therapeutics

For additional details about Altay Therapeutics, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.